BioWorld MedTech

July 10, 2012

Deals roundup: Luminex in agreement to acquire GenturaDX for $50 million

Luminex (Austin, Texas) reported a definitive agreement to acquire privately-held, GenturaDx (Hayward, California), a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. Read More

Lab tech invents system to prevent needle sticks

Report from Europe: Lab21 gets 5M from Clydesdale Bank for international expansion

Washington roundup: ACR: Part B imaging cuts for 2013 'arbitrary and capricious'

Financings roundup: CartiHeal raises up to $10M in most recent funding drive

Coming Wednesday in MDD Perspectives

Agreements/contracts: KM&T, Medworxx unite on patient flow diagnostic

People in the News

Patents roundup: Unilife secures patent for Unifill syringe technology

Med-Tech Notes: BSD sells MicroThermX to Miami hospital

Product Briefs

CareFusion recalls AirLife infant breathing product

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...

Liver with hepatitis viruses, blood cells

Recombinant vaccine inhibits HBV-associated HCC growth

BioWorld Science

Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....